Skip to main content

Market Overview

UBS Data Shows Expedia, Priceline Doing Well...But Don't Sleep On TripAdvisor

Share:
UBS Data Shows Expedia, Priceline Doing Well...But Don't Sleep On TripAdvisor

UBS’ Eric J. Sheridan reiterated Buy ratings for Expedia Inc (NASDAQ: EXPE) and Priceline Group Inc (NASDAQ: PCLN), while saying that he was “incrementally more positive” on Neutral-rated Tripadvisor Inc (NASDAQ: TRIP). The price targets for Expedia and Priceline are at $145, $1,525, respectively. The price target for TripAdvisor has been raised from $68 to $69.

Commenting on the Instant Booking [IB] debate, Sheridan said that investors are concerned about moves to address leakage, or lost traffic conversion), in terms of travel research and conversion. TripAdvisor’s IB continues to be on the minds of all online travel investors, who consider this data for its impact on the company as well as the broader industry.

“While the transition continues to cause rev headwinds & deleverage in the medium-term, we see increased signs of TRIP’s monetization opportunity from “plugging the leak” – with two illustrative frameworks suggesting potential for ~10% upside to 2017 Street Click-based ad revs – conservatively showing overall hotel shopper conversion before 3%, which appears achievable to us,” Sheridan wrote.

Related Link: Piper Jaffray Upgrades Expedia To Overweight, Raises Target To $140

The analyst added that TripAdvisor is likely to benefit from higher repeat/return visits and engagement, both of which are concepts that the Street seemed to be underappreciating.

Incrementally Positive

Mentioning that he was “incrementally more positive” on TripAdvisor, Sheridan said that its risk-reward had improved. Although there are medium-term headwinds to the 1H16 estimates, there is a “growing chance” of the company beating Street expectations in 2H16 and 2017, backed by increased IB supply, better repeat/return behavior, and improved conversion.

Latest Ratings for EXPE

DateFirmActionFromTo
Mar 2022Deutsche BankInitiates Coverage OnBuy
Feb 2022Morgan StanleyMaintainsEqual-Weight
Feb 2022CitigroupMaintainsNeutral

View More Analyst Ratings for EXPE

View the Latest Analyst Ratings

 

Related Articles (EXPE + PCLN)

View Comments and Join the Discussion!

Posted-In: Analyst Color Long Ideas Price Target Reiteration Travel Analyst Ratings Trading Ideas General Best of Benzinga

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com